We work to raise awareness, drive research funding, and promote policy changes to improve access to care and support for individuals affected by rare diseases.
We focus on promoting innovative therapies, supporting clinical trials, and shaping policies to improve oncology-related health outcomes and harness the potential of oncology innovations.
We work to accelerate the translation of innovative therapies from the lab to clinical practice, advocate for supportive policies, and foster collaboration between scientists, clinicians, and regulatory bodies.
We collaborate with healthcare professionals, researchers, and policymakers to advance treatment methodologies, improve patient outcomes, and influence health care practices.
We work to advance clinical practices, support innovative therapies, and advocate for policies that enhance the quality of life for individuals living with misophonia.
We work to advance clinical practices, support innovative therapies, and advocate for policies that enhance the quality of life for individuals living with bipolar disorder.
We investigate the latest scientific discoveries and therapeutic approaches to combat Alzheimer's and related dementias. We aim to accelerate the development of effective treatments, advocate for increased research funding, and influence policy to improve care and support for individuals affected by dementia and Alzheimer's disease.
We address issues related to cognitive function and neurological well-being, to promote preventative measures, innovative treatments, and public policies aimed at enhancing brain health across the lifespan.
Our work in neurological health helps advance the understanding and treatment of neurological disorders. We inform policy, promote innovative therapies, and support initiatives that improve the diagnosis, management, and overall care for conditions affecting the nervous system.
We investigate and support advancements in the discovery and creation of novel pharmaceuticals. We facilitate collaboration between researchers, pharmaceutical companies, and regulatory agencies to accelerate the development and approval of innovative drugs that address unmet medical needs.
